XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES    
Net loss $ (38,289) $ (47,005)
Adjustments to reconcile net loss to net cash used by operating activities    
Depreciation and amortization 6,636 8,563
Equity based compensation 10,081 5,306
Change in fair value of derivative liability (832) 1,578
Accretion of lease liability 4,876 (107)
Write-off of investment   759
Write-off of receivable   518
Write-off of deposit   424
Write-off of fixed asset from terminated lease 1,210  
Accretion of contingent consideration 505 1,532
Accretion of convertible debenture and interest 4,048 1,009
Accrued interest on notes payable 7,913 3,073
Interest accrued - lease receivable 667 (312)
Deferred taxes 1,319 6,530
Impairment of goodwill and intangibles   16,748
Tax adjustment to goodwill   (1,406)
Gain on sale of dispensaries   (13,454)
Gain on sales lease back 1,210 (3,345)
Equity issued to pay consulting fees   644
Changes in operating assets and liabilities 7,643 5,531
ACTIVITIES 5,777 (13,414)
Net cash provided by (used in) discontinued investing activities   (627)
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES 5,777 (14,041)
CASH FLOWS FROM INVESTING ACTIVITIES    
Long term deposits (481)  
Issuance of notes receivable, net of repayments   (3,503)
Notes receivable repayments 246 782
Sale of dispensary and interests in cannabis licenses 1,093 25,423
Sale lease back transactions   32,189
Purchases of property and equipment (13,872) (13,875)
NET CASH PROVIDED BY (USED IN) CONTINUED INVESTING ACTIVITIES (13,014) 41,016
Net cash provided by (used in) discontinued investing activities   (1,679)
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (13,014) 39,337
CASH FLOWS FROM FINANCING ACTIVITIES    
Payment of contingent consideration (1,201)  
Sale of stock with warrants, net of issuance costs   12,134
Issuance of convertible notes, net of costs 14,376 8,636
Proceeds from the exercise of warrants 1,949 1,352
Proceeds from the exercise of stock options 1,512  
Repayment of convertible debentures   (37,813)
Repayment of notes payable (5,750) (2,317)
NET CASH PROVIDED BY (USED IN) CONTINUED FINANCING ACTIVITIES 10,886 (18,008)
Net cash provided by discontinued financing activities   3,503
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES 10,886 (14,505)
NET INCREASE (DECREASE) IN CASH 3,649 10,791
CASH, BEGINNING OF YEAR 18,932 8,141
CASH, END OF YEAR $ 22,581 $ 18,932